Biomarkers of acute injury: predicting the long-term outcome after transplantation.
Biomarkers of ischemia-reperfusion injury allow risk stratification and early identification of delayed graft function after kidney transplantation. Welberry Smith et al. describe a novel serum biomarker, aminoacylase-1, that not only is associated with delayed graft function but can predict the long-term outcome years after transplantation.